Overview
MASA syndrome is a rare X-linked neurological disorder whose name is an acronym for its four cardinal features: Mental retardation (intellectual disability), Aphasia (delayed speech), Shuffling gait (spastic paraplegia), and Adducted thumbs. It is caused by mutations in the L1CAM gene located on the X chromosome (Xq28), which encodes the L1 cell adhesion molecule, a protein critical for nervous system development including neuronal migration, axon guidance, and myelination. MASA syndrome is part of a spectrum of L1CAM-associated disorders that also includes X-linked hydrocephalus (HSAS), X-linked complicated hereditary spastic paraplegia type 1 (SPG1), and X-linked agenesis of the corpus callosum. These conditions are collectively referred to as L1 syndrome. The condition primarily affects the central nervous system. Males are predominantly affected, while carrier females are usually asymptomatic or mildly affected. Key clinical features include mild to moderate intellectual disability, delayed speech and language development, lower limb spasticity resulting in a characteristic shuffling gait, and clasped or adducted thumbs due to absence or hypoplasia of the extensor pollicis longus or brevis muscles. Additional features may include hypoplasia or agenesis of the corpus callosum, mild to moderate ventricular enlargement (hydrocephalus), and variable degrees of corticospinal tract dysfunction. Brain MRI may reveal structural abnormalities including corpus callosum anomalies and enlarged ventricles. There is currently no cure for MASA syndrome. Treatment is supportive and multidisciplinary, focusing on managing symptoms and optimizing developmental outcomes. This may include physical therapy and orthopedic interventions for spasticity and gait abnormalities, speech and language therapy, special education services, and occupational therapy. In cases with significant hydrocephalus, neurosurgical intervention such as ventriculoperitoneal shunting may be required. Genetic counseling is important for affected families given the X-linked inheritance pattern.
Clinical phenotype terms— hover any for plain English:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for MASA syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for MASA syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to MASA syndrome.
Community
No community posts yet. Be the first to share your experience with MASA syndrome.
Start the conversation →Latest news about MASA syndrome
No recent news articles for MASA syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about MASA syndrome
What is MASA syndrome?
MASA syndrome is a rare X-linked neurological disorder whose name is an acronym for its four cardinal features: Mental retardation (intellectual disability), Aphasia (delayed speech), Shuffling gait (spastic paraplegia), and Adducted thumbs. It is caused by mutations in the L1CAM gene located on the X chromosome (Xq28), which encodes the L1 cell adhesion molecule, a protein critical for nervous system development including neuronal migration, axon guidance, and myelination. MASA syndrome is part of a spectrum of L1CAM-associated disorders that also includes X-linked hydrocephalus (HSAS), X-lin
How is MASA syndrome inherited?
MASA syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does MASA syndrome typically begin?
Typical onset of MASA syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat MASA syndrome?
4 specialists and care centers treating MASA syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.